Clinical Cancer Research Meeting Calendar Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gangnus, R.
Right arrow Articles by Speicher, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gangnus, R.
Right arrow Articles by Speicher, M. R.
Clinical Cancer Research Vol. 10, 3457-3464, May 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Genomic Profiling of Viable and Proliferative Micrometastatic Cells from Early-Stage Breast Cancer Patients

Rainer Gangnus1,2, Sabine Langer1,2, Elisabeth Breit3, Klaus Pantel3 and Michael R. Speicher1,2

1 Institut für Humangenetik, Technische Universität München, München; 2 Institut für Humangenetik, GSF Forschungszentrum für Umwelt und Gesundheit, Neuherberg; and 3 Institut für Tumorbiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

Purpose: Metastases in distant organs are the major cause of death for cancer patients, and bone marrow is a prominent homing organ for early disseminated cancer cells. However, it remains still unclear which of these cells evolve into overt metastases. We therefore established a new approach based on the analysis of viable and proliferating cancer cells by single-cell comparative genomic hybridization.

Experimental Design: The bone marrow of early-stage breast tumor patients (pN0M0) was screened for tumor cells by immunostaining. By applying special short-term culturing, we selected for viable and proliferative tumor cells. The short-term culturing allowed us to evaluate the proliferative potential of micrometastatic cells, which we had previously shown to represent an independent prognostic marker. We assessed genomic changes in single disseminated cancer cells by single-cell comparative genomic hybridization.

Results: We found that these viable disseminated cancer cells already had a plethora of copy number changes in their genome. All of these cells showed chromosomal copy number changes with a substantial intercellular heterogeneity and differences to the matching primary tumors.

Conclusions: The established experimental strategy might pave the way for the identification of metastatic stem cells in cancer patients. Our preliminary results support the new concept that early disseminated cancer cells evolve independently from their primary tumor.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
J. B. Geigl, A. C. Obenauf, J. Waldispuehl-Geigl, E. M. Hoffmann, M. Auer, M. Hormann, M. Fischer, Z. Trajanoski, M. A. Schenk, L. O. Baumbusch, et al.
Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays
Nucleic Acids Res., June 18, 2009; (2009) gkp526v1.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Alix-Panabieres, S. Riethdorf, and K. Pantel
Circulating Tumor Cells and Bone Marrow Micrometastasis
Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Vincent-Salomon, F C Bidard, and J Y Pierga
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues
J. Clin. Pathol., May 1, 2008; 61(5): 570 - 576.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Fiegler, J. B. Geigl, S. Langer, D. Rigler, K. Porter, K. Unger, N. P. Carter, and M. R. Speicher
High resolution array-CGH analysis of single cells
Nucleic Acids Res., February 16, 2007; 35(3): e15 - e15.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Suzuki, E. S. Mose, V. Montel, and D. Tarin
Dormant Cancer Cells Retrieved from Metastasis-Free Organs Regain Tumorigenic and Metastatic Potency
Am. J. Pathol., August 1, 2006; 169(2): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
K. Pantel and U. Woelfle
Circulating Tumor Cells as an Indicator of Invasion
Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 116 - 119.
[Full Text] [PDF]


Home page
NEJMHome page
S. Braun, F. D. Vogl, B. Naume, W. Janni, M. P. Osborne, R. C. Coombes, G. Schlimok, I. J. Diel, B. Gerber, G. Gebauer, et al.
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
N. Engl. J. Med., August 25, 2005; 353(8): 793 - 802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.